PainQx Inc

PainQx IncProfile last edited on: 8/28/2019
16 Washington PlaceNew York, NY 10011
|
Business Identifier: Next generation approach objectively to measure pain in humans
Public Profile:
Originally working in conjunction with the Brain Research Lab at NYU School of Medicine, PainQx Inc, has developed a patented method for the objective, quantitative measurement of pain. Functioning as a diagnostic/software company, this next generation approach to objectively measure pain is achieved by assessing neural activity from a patient’s brain and processing and decoding the data through proprietary algorithms. The output is a scaled pain and neurological side effects biomarker that is directly correlated to a patient’s pain state. One application is use of the system as a clinical assessment tool by companies using pain as a primary or secondary clinical end point to measure their drug’s and/or device’s efficacy. Another application would be use of the system to reduce abuse of pain medications
Originally working in conjunction with the Brain Research Lab at NYU School of Medicine, PainQx Inc, has developed a patented method for the objective, quantitative measurement of pain. Functioning as a diagnostic/software company, this next generation approach to objectively measure pain is achieved by assessing neural activity from a patient’s brain and processing and decoding the data through proprietary algorithms. The output is a scaled pain and neurological side effects biomarker that is directly correlated to a patient’s pain state. One application is use of the system as a clinical assessment tool by companies using pain as a primary or secondary clinical end point to measure their drug’s and/or device’s efficacy. Another application would be use of the system to reduce abuse of pain medications
|